1
/
of
1
Monoclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
TRV-009216-01
Antibodies
Apoptosis & Cell Death Antibodies
Monoclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
SKU:TRV-009216-01
Regular price
$91.40
Regular price
Sale price
$91.40
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Monoclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Related categories:
Antibodies,
Apoptosis & Cell Death Antibodies
Share

Product specifications
| Alternative Name | CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand |
| Name Synonym | Tumor Necrosis Factor Related Apoptosis Inducing Ligand |
| Uniprot | P50591 |
| Field of Research | Apoptosis; Tumor immunity |
| Applications | WB; ICC/IF |
| Organism Species | Homo sapiens (Human) |
| Reactivity | Mu; Ra |
| Concentration | 1mg/mL |
| Buffer | 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Isotype | IgG2b Kappa |
| Host | Mouse |
| Host or Source | Mouse |
| Source | Monoclonal antibody preparation |
| Immunogen | RPA139Hu01-Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) |
| Recommended Usage | Western blotting: 0.5-2µg/mL; < br/> Immunohistochemistry: 5-20µg/mL; < br/> Immunocytochemistry: 5-20µg/mL; < br/> Optimal working dilutions must be determined by end user. |